Viewing Study NCT03803761


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2025-12-29 @ 7:32 AM
Study NCT ID: NCT03803761
Status: WITHDRAWN
Last Update Posted: 2023-09-25
First Post: 2019-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-02-13
Start Date Type: ESTIMATED
Primary Completion Date: 2022-02-19
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-02-19
Completion Date Type: ESTIMATED
First Submit Date: 2019-01-14
First Submit QC Date: None
Study First Post Date: 2019-01-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-22
Last Update Post Date: 2023-09-25
Last Update Post Date Type: ACTUAL